Member Info for DJP4976

Anyone exercising warrants at or below 0.4p will be holding them for future gains, it makes absolutely no sense to buy something and instantly be holding a loss, ie, when those warrants were exercised the share price was below 0.4p and instantly the warrant holder is at a loss, may aswel buy them on market

Lastly the company has plenty of warrants which once the share price is comfortable above 0.4p will see them funded for the foreseeable future, almost 450m of these warrants are due for expiry in May this year - so if they are to be exercised the share price needs to get a shift on ASAP

Also loads of trolls on this board and rightly so given the past of this company. People talking about MAST £5m not going far, KIBO past, LC salary etc etc.

All of this is totally irrelevant to me.

The company as it currently is today, is undervalued by at least 100%

£12.75m worth of MED shares at IPO price - potentially going to be higher on first day of IPO, but let’s just say £12.75m for now.

KAT £2.1m worth

So roughly £15m of value without anything else attributed.

£15m into 2.35b shares = 0.64p per Kibo share

MED alone attributes 0.54p per share of value

This should now build into IPO in a couple of weeks and I have a feeling could go bang busters on MED IPO as they are in a hot sector clean energy

Clearly you don’t understand how warrants work, no warrant holder in their right mind would want to cash in 0.4p warrants whilst share price remains at or below 0.4p, for those warrants to be well in the money the share price needs to be 0.5p+ imo

results now in a couple of weeks - encouragingly this statement...

‘The audit process is close to completion, and no issues or concerns have arisen.’

Which may ease a few concerns about the delays. I also look forward to the current Trading update within

Lombard had 17.03% which was 221m

Volume yesterday 150m and according to today’s TR1 they sold 114m to end up with 8.24% or 107m - I’m presuming there are going to be a few big delayed trades show up over the next few days to account for these sells.

Today’s volume was 97m so let’s say they’ve shifted another 50m, again delayed trades to show IMO.

I reckon they have 50m or so left which if we get another decent volume day tomorrow, should make for a very very interesting Friday run

Took a few myself yesterday, sold out previously after it broke below .3 previous support. Now back at another old resistance level around 0.18-0.2p which should now act as fairly decent support.

There’s clearly been a big seller the last couple weeks or so, I honestly don’t think it’s Myles, but I’m banking on whoever it is being very close to out now.

More contracts were promised in the coming months and it’s been 2-3 months since the last, again could be expecting another anytime.

£1.1m cash, £2.3m MC - we’ve seen some tech companies go on huge runs lately, will MOS be the next big mover from such a low starting point - good risk reward at this level IMO

GM - General Meeting where the issue of placing shares was approved and change in investing policy, and appointment of new directors etc

Clearly someone building a position here today, some of the biggest trades we’ve seen going in for a few weeks and a number of them, even when we see some large sells, 2 minutes later another 1m round buy went in! Wonder if they want more! Can see this testing 1p before news

We’ve seen the last week or so how little it’s taking to swing this red or blue on minimal volume - some news and it’s quickly testing 1p area IMO - £6k of trades today and +7%

Nice and quiet here atm, today was the lowest volume day since placing GM to approve placing and investing strategy change, sellers seem to have all but dried up at this level.

Since GM there has been almost 290m volume, of which almost all of that has been above 0.6p and upto a high of 0.85p, so anyone from the placing that wanted out has now done so and plenty of traders/investors in at these current prices and higher.

The placing was 130m, but Angus took 20m so only 110m went to retail, so in my opinion it has been completely churned through now, pre more Significant news flow which is key IMO.

Secondly the BID today was one of the strongest I’ve seen it for a while, I could sell my whole holding 3m worth at 0.632 in one hit (£19k) that’s a lumpy amount for a £1.5m MC company.

Looking forward to next news and seeing where the share price goes from there. 1p would be a good near term target, it could be a sticking point but if 1p were to break, the jumps higher will become bigger and quicker as not much resistance up to 1.5 and then 2p

Name change done, opens the window to more meaningful newsflow now - since GM the entire shares in issue have been traded and more which should have totally cleared the placing, so it’s now set up perfectly for newsflow

6m buy show on ADVFN likely placed on Friday when we saw that strength and filled today. Sellers are being mugged here, I think there bigger things at play which I’m sure we’ll find out about shortly! Anyway that isn’t punt money £44k and nearly 3% in one hit.

Not showing on LSE atm as prices have been a bit messed up all day

In today’s RNS the caption

‘In addition a key consultant to the Company, has been granted 1,000,000 options on the same terms.’

Who is this key advisor, why are they key and why haven’t the company named who it is? Very interesting and think we could find out fairly soon.

Have added further at .55 and under, and now time to sit back and let it play out - if it goes the way I think, genuine 10 bag opportunity from the placing price given time from such a low MC starting point. Angus confident to take a big wedge at .6p average

Having bought on market straight after the recent change in strategy and placing RNS, I’m really excited for this one.

It’s plays like this that I love, very thinly traded, tiny Market cap, all time lows, roughly 50% of shares held by current directors that are supportive of the changes, incoming CEO Angus Forrest has a decent history, and is confident to take 10%+ of the enlarged shares after GM with 25m £150k worth, some at placing price and some at 1p.

I remember one of he’s last companies IMTK doing me almost 200% when it went from 4p to 12p or so, and this in my opinion will do the same whether it’s before or after the GM.

I’ve took an initial position but will happily add further if it dips back far enough as I think we could see a very decent move coming here

I have been taking a look at the share capital and what price previous raises etc have been carried out at.

Total of 247m shares in issue when Finnaust RTO’d in 2013 with placing at 5p

49m shares was placed at 2.25p in October 2014

175m shares placed in December 2015 (165m issued to western areas ltd as part of an acquisition of 60% of their interest in Greenland licences with option to purchase the remaining 40%) and 10m placing at 2p

March 2016 placing 50m at 2p (£1m)

76m shares placed at 7p December 2016 (£5m) including 45m of western areas ltd shares placed to new Insti investors also at 7p

£3.5m 29m placed at 12p - June 2017
along with 138m shares again from western areas ltd holding placed with insti’s at 12p

So basically all shares received by western areas ltd at 2p level with regard to the acquisition are in new hands from 7p and majority at 12p

Feb 2018 raised £17m at 22p - 77m shares

November 2019 - raises 115m shares £11.5m at 10p

So to summarise

•Roughly 25% of shares in at 5p from IPO in 2013
•Roughly 10% of shares in at 2-2.25p 2014-2016
•Roughly 15% of shares in at 7p Dec 2016
•Roughly 20% of shares in at 12p June 2017
•Roughly 10% of shares in at 22p Feb 2018
Roughly 15% of shares in at 10p Nov 2019

90% plus of the equity is in at 5p+ with 45% or so in at 10p+

Outstanding amounts are from warrant and option exercises at various prices.

Directors have decent amounts of options starting from 10p all the way up to 30p - pretty much all legacy warrants and options have expired baring a small few at 7p

For me this is a bargain at current prices, We’ve had the delay RNS of the Rio smeltering test and also Disko work being postponed all due to Covid19 which has suppressed the price, bad news now out the way and priced in, throw in a bit of good news and it’ll soon be heading back to the last placing price of 10p and beyond imo!

I reckon they’ll try and drop it first thing to maybe 16p area (which was previous resistance until we broke out of that today) and then it’ll bounce from there. If you were keeping an eye on trades today MM’s went defensive late on, i.e. they opened the spread up letting people sell mid 16’s but wouldn’t allow buying anywhere near that price, was 17.6p to buy into close. That suggests they are trying to pick up cheapies but don’t want to sell them back anywhere near that area, usually suggests a bottom is close!

Overall a good day on a bad market day in general, I still believe if this news was released last week we would have been testing 30p intraday rather than 20p.

Anyway onwards and upwards, 20p level is now the biggie to break, if that goes it opens up a very decent move imo, further news due on a number of fronts now not only COVID news, so can only see it gaining momentum from here.

Well well well, that’s a bit of monster news! Can only see this going one way over the next few weeks now

https://translate.google.com/translate?hl=en&sl=fr&u=https://icfrc.fr/covid-19-un-nouveau-comite-de-scientifiques-pour-conseiller-le-gouvernement-sur-les-traitements-et-les-tests-contre-le-coronavirus/&prev=search

So IMM scientific member Prof Muller one of 12 appointed to the French Research and expert analysis committee by president Macron for COVID-19, and also Imm subsidiary Ureka Pharma entered a consortium funded by the French state for C19 also.

I like this bit

‘ She will be accompanied in particular by Sylviane Muller, researcher in immunology and therapeutic chemistry on the Strasbourg university campus. Specialist in autoimmune diseases, she is known to be at the origin of a promising treatment currently in clinical study against lupus. The possibility of treating Covid-19 based on chloroquine or one of its derivatives is mentioned and is being analyzed, these compounds being already used for the treatment of several auto-immune diseases of the lupus type.’